摘要
目的:探讨利凡诺联合米非司酮与米索前列醇终止中期妊娠的临床疗效。方法:选择2005年6月～2009年9月期间我站收治的要求终止妊娠的118例孕妇,随机分为观察组和对照组,每组59例。观察组采用利凡诺、米非司酮与米索前列醇联合治疗,对照组则采用利凡诺单独治疗,对两组患者的总产程和引产效果进行比较分析。结果:与对照组比较,观察组总产程明显缩短,差异有统计学意义(P<0.05);而且观察组成功的比率明显高于对照组,差异有统计学意义(P<0.05);两组成功引产的总比率比较,差异无统计学意义(P>0.05)。结论:利凡诺联合米非司酮与米索前列醇是一种终止中期妊娠有效且可靠的方法。
Objective： To investigate the clinical efficacy of Rivanol termination of the mid-term pregnancy with Mifepristone and Misoprostol. Methods： From June 2008 to September 2009 in our station, 118 cases of pregnant women to terminate pregnancy were selected, the patients were randomly divided into the observation group and the control group, 59 cases in each group. The observation group were treated with Rivanol, Mifepristone and Misoprostol combination therapy, the control group was used Rivanol alone, the total production process and induced abortion effects of patients in two groups were compared and analyzed. Results. Compared with the control group, the overall delivery process of the observation group was significantly shorter, the differences was statically significant （P〈0.05）. At the same time, compared with the control group, the success rate of the observation group was significantly higher, the differences was statically significant （P〈0.05）. The overall rate of successful induction of labor of two groups were compared, the difference was not statistically significant （P〉0.05）. Conclusion： Rivanol termination of the mid-term pregnancy with Mifepristone and Misoprostol is an effective and reliable method.
出处
《中国医药导报》
CAS
2010年第13期68-69,共2页
China Medical Herald
